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BACKGROUND: Attenuated auditory mismatch negativity (MMN) is a robust
finding in schizophrenia and has been proposed as an endophenotype for the disorder.
Glutamatergic dysfunction at the genetic and protein level has been observed in
schizophrenia and may underlie reduced MMN. Exogenous cannabinoids such as
delta-9-tetrahydrocannabinol (THC) modulate CB1 regulation of NMDA receptors
and disrupt normal glutamatergic functioning. Acute administration of cannabinoids
and NMDA receptor antagonists has been shown to modulate MMN. Cannabis is a
known risk factor for the development of schizophrenia and psychosis in vulnerable
individuals. Chronic exposure has been shown to lead to similar structural and
cognitive deficits observed in schizophrenia, suggesting a common underlying
pathology. This study aimed to investigate the effects of regular long-term cannabis
use on MMN as a vulnerability marker of schizophrenia and psychosis.
METHODS: Long-term heavy cannabis users (n=47) and healthy age and gender
matched non-user controls (n=47) were compared on MMN response to duration,
frequency and intensity deviants presented in a multi-feature paradigm. Tones were
presented binaurally using headphones at a constant 500ms stimulus onset asynchrony
with a 5ms rise/fall time. MMN waveforms for each condition were extracted from
difference waveforms between the standard (50ms, 80dB, 1000Hz, 82%) and deviant
(duration, 100ms, 6%; frequency, 1200Hz, 6%; intensity, 90dB, 6%) event related
potentials. EEG was recorded with an initial nose reference and extracted waveforms
were re-referenced to the average of the mastoids. Cannabis users had a mean
frequency use of 24.37 days/month and a mean quantity use of 406.38 cones/month.
Cannabis users remained abstinent for a minimum of 12 hours prior to testing.
Cannabis use parameters and symptomatic measures were examined in relation to
MMN peak amplitude and latency at the Fz electrode.
RESULTS: Group differences showed reduced MMN peak amplitude in the cannabis
group relative to controls for duration (F(1,78) = 35.55, p <.001) and frequency
(F(1,80) = 9.38, p = .003) conditions. Peak amplitude for intensity MMN did not
differ between groups. No group differences were observed for MMN peak latency
(all F values <1). Exploratory analysis of symptomatic measures showed that
cannabis users scored significantly higher than controls on Community Assessment of
Psychiatric Symptoms (CAPE) total frequency scores (p = 0.01) and CAPE negative
dimension frequency scores (p = 0.034). Cannabis users also scored higher on
Schizotypal Personality Questionnaire (SPQ) total scores (p = 0.009) and on several
subscale scores. None of the symptomatic measures nor any cannabis use parameters
correlated with MMN peak amplitude in the duration or frequency condition.
DISCUSSION: The current findings provide support for chronic cannabis use as an

increased risk factor in the development of depressive and negative symptoms. The
current data also provide some evidence of a glutamatergic dysfunction in regular
long-term cannabis users, indicated by reduced MMN amplitude to frequency and
duration deviants. Attenuated MMN to changes in duration and frequency of auditory
stimuli is a robust finding in schizophrenia. The current findings of reduced MMN
amplitude to duration and frequency deviants in cannabis users suggest that chronic
cannabis use may affect early sensory information processing in a similar way to that
observed in schizophrenia. This could potentially be explained by glutamatergic
dysfunction as a result of prolonged exposure to cannabis and inform mechanisms by
which cannabis could trigger psychosis.

